Joseph Edelman’s Perceptive Advisors Buys More AcelRx Pharmaceuticals

Joseph Edelman‘s fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again, after disclosing a buy of around 360,700 shares a couple of days ago. This time, Perceptive acquired 155,000 shares, bringing the position to a total of some 6.37 million shares. The average purchase price amounts to around $6.87 per share.

AcelRx Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Heartland Advisors Discloses Changes in its Albany International and Gulf Island Holdings

Bill Ackman Cuts Stake in LSE-listed Platform Specialty Products

Chuck Royce Discloses Moves in Vera Bradley, Graham Corp & Others

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!